UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 3.435

Sortiert nach

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

The New England journal of medicine, 2015-05, Vol.372 (22), p.2087-2096

2015

Volltextzugriff (PDF)

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

The New England journal of medicine, 2016-09, Vol.375 (11), p.1019-1032

2016

Volltextzugriff (PDF)

Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy

Clinical infectious diseases, 2012-11, Vol.55 (10), p.1320-1328

2012

Volltextzugriff (PDF)

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

The Journal of infectious diseases, 2018-05, Vol.217 (11), p.1750-1760

2018

Volltextzugriff (PDF)

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

The Journal of infectious diseases, 2015-04, Vol.211 (8), p.1279-1287

2015

Volltextzugriff (PDF)

Th1 memory differentiates recombinant from live herpes zoster vaccines

The Journal of clinical investigation, 2018-10, Vol.128 (10), p.4429-4440

2018

Volltextzugriff (PDF)

Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years

The Journal of infectious diseases, 2016-06, Vol.213 (12), p.1872-1875

2016

Volltextzugriff (PDF)

Varicella-Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine

The Journal of infectious diseases, 2008-03, Vol.197 (6), p.825-835

2008

Volltextzugriff (PDF)

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

The Journal of infectious diseases, 2017-12, Vol.216 (11), p.1343-1351

2017

Volltextzugriff (PDF)

Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study

PLoS medicine, 2013-04, Vol.10 (4), p.e1001420

2013

Volltextzugriff (PDF)

Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults

The Journal of infectious diseases, 2016-01, Vol.213 (1), p.14-22

2016

Volltextzugriff (PDF)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

The Journal of infectious diseases, 2017-12, Vol.216 (11), p.1352-1361

2017

Volltextzugriff (PDF)

Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve

The Journal of infectious diseases, 2014-11, Vol.210 (10), p.1573-1581

2014

Volltextzugriff (PDF)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2341456-2341456

2024

Volltextzugriff (PDF)

Zoster Vaccine: Current Status and Future Prospects

Clinical infectious diseases, 2010-07, Vol.51 (2), p.197-213

Oxman, Michael N.

2010

Volltextzugriff (PDF)

Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in AD

Experimental gerontology, 2024-06, Vol.190, p.112411-112411, Article 112411

2024

Volltextzugriff (PDF)

Effectiveness of herpes zoster vaccination in an older United Kingdom population

Vaccine, 2018-04, Vol.36 (17), p.2371-2377

2018

Volltextzugriff (PDF)

Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial

The Lancet infectious diseases, 2016-08, Vol.16 (8), p.915-922

2016

Volltextzugriff (PDF)

Varicella Zoster Virus—Specific Immune Responses to a Herpes Zoster Vaccine in Elderly Recipients With Major Depression and the Impact of Antidepressant Medications

Clinical infectious diseases, 2013-04, Vol.56 (8), p.1085-1093

2013

Volltextzugriff (PDF)

Identification and Characterization of CD4 + T Cell Epitopes after Shingrix Vaccination

Journal of virology, 2020-11, Vol.94 (24)

2020

Volltextzugriff (PDF)

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial

Vaccine, 2015-02, Vol.33 (6), p.789-795

2015

Volltextzugriff (PDF)

Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Clinical infectious diseases, 2017-10, Vol.65 (7), p.1174-1182

2017

Volltextzugriff (PDF)

Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination

Journal of virology, 2020-06, Vol.94 (13)

2020

Volltextzugriff (PDF)

Zoster Vaccination Increases the Breadth of CD4⁺ T Cells Responsive to Varicella Zoster Virus

The Journal of infectious diseases, 2015-10, Vol.212 (7), p.1022-1031

2015

Volltextzugriff (PDF)

A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus

Human vaccines & immunotherapeutics, 2017-08, Vol.13 (8), p.1789-1797

2017

Volltextzugriff (PDF)

1 – 25 von 3.435

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.047)
Mit Volltextzugriff
(2.472)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(3.094)
Science & Technology
(2.789)
Life Sciences & Biomedicine
(2.746)
Male
(1.493)
Immunology
(1.490)
Female
(1.477)
Herpes Zoster
(1.269)
Adult
(1.233)
Infectious Diseases
(1.187)
Middle Aged
(1.158)
Herpesvirus 3, Human - Immunology
(1.102)
Herpes Zoster - Immunology
(1.086)
Aged
(983)
Biological And Medical Sciences
(935)
Medical Sciences
(806)
Varicella-Zoster Virus
(803)
Microbiology
(716)
Child
(645)
Herpes Zoster - Prevention & Control
(639)
Adolescent
(574)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Persistence of the Efficacy of Zoster Vaccine in the Shingles Prevention Study and the Short-Term Persistence Substudy

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study

Th1 memory differentiates recombinant from live herpes zoster vaccines

Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years

Varicella-Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study

Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

Fold Rise in Antibody Titers by Measured by Glycoprotein-Based Enzyme-Linked Immunosorbent Assay Is an Excellent Correlate of Protection for a Herpes Zoster Vaccine, Demonstrated via the Vaccine Efficacy Curve

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review

Zoster Vaccine: Current Status and Future Prospects

Associations of infections and vaccines with Alzheimer's disease point to a role of compromised immunity rather than specific pathogen in AD

Effectiveness of herpes zoster vaccination in an older United Kingdom population

Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial

Varicella Zoster Virus—Specific Immune Responses to a Herpes Zoster Vaccine in Elderly Recipients With Major Depression and the Impact of Antidepressant Medications

Identification and Characterization of CD4 + T Cell Epitopes after Shingrix Vaccination

Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial

Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination

Zoster Vaccination Increases the Breadth of CD4⁺ T Cells Responsive to Varicella Zoster Virus

A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus

Suchergebnisse filtern